NeuroBell
Latest round
- Seed
Last raised
- Oct 2025
Total raised
- $1.7M
Investors
- 4
About NeuroBell
Founded in 2015 and based in Cork, Ireland, NeuroBell Ltd. operates as a medical equipment company that offers neonatal EEG monitoring solutions. The company is a spin-out of University College Cork and the Irish Centre for Maternal and Child Health Research (Infant). The firm was founded by its CEO, Mark O’Sullivan, CSO, Alison O’Shea, and CTO, Colm Murphy. In June 2026, NeuroBell Ltd. NeuroBell provides and develops a novel medical device that detects seizures in newborns. The company’s product line includes a pocket-sized and wireless EEG (electroencephalography) monitor, which is a medical device that leverages machine learning to detect and monitor neonatal seizures in newborns.
Who invested in NeuroBell
4 investors across 1 round
See all investors in NeuroBell
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 25, 2025
Amount
$1.7M
Investors
Questions about NeuroBell
Who invested in NeuroBell?
NeuroBell has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NeuroBell raised?
NeuroBell has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NeuroBell last raise money?
NeuroBell's most recent round on record is a Seed, in Oct 2025.
What does NeuroBell do?
Founded in 2015 and based in Cork, Ireland, NeuroBell Ltd.
Where is NeuroBell headquartered?
NeuroBell is headquartered in Cork, Ireland.
Which VCs invest in companies like NeuroBell?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back medical devices & equipment companies at NeuroBell's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like NeuroBell? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.